This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Global digitaltherapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. The post [DarioHealth in Yahoo Finance] Walmart Starts Distributing the DarioHealth Digital Diabetes Management System appeared first on OurCrowd.
The post [DarioHealth in Yahoo Finance] DarioHealth Expands Offering to Include Behavioral Health appeared first on OurCrowd. NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp. Read more here.
(Nasdaq: DRIO), a pioneer in the global digitaltherapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.
(Nasdaq: DRIO), a global digitaltherapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. Food and Drug. Read more here.
The curriculum will provide training in subjects such as managerial finance, accounting, and financial statement preparations; human resources development and management; business model design; marketing and customer development; and more. The company will focus on building its digital proprietary platform and easy-to-use digital application.
(Nasdaq: DRIO), a pioneer in the global digitaltherapeutics market, today announced that it will host a key opinion leader (KOL) call on digitaltherapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. Eastern Time. Read more here.
BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digitaltherapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19.
Nasdaq: DRIO), a pioneer in the global digitaltherapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). DarioHealth Corp. Read more here.
NASDAQ: DRIO), a pioneer in the global digitaltherapeutics market, announced today the launch of its digitaltherapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. DarioHealth Corp. Read more here.
. (“DarioHealth” or “Dario”) (DRIO), a leading, global digitaltherapeutics company, today announced that it has received a notice of allowance from the U.S. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. ” Read more here.
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digitaltherapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) Read more here.
. (“DarioHealth” or “Dario”) (DRIO), a leading, global digitaltherapeutics company, today announced that it has received a notice of allowance from the U.S. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. ” Read more here.
startup that offers personalized digitaltherapeutics for women going through menopause, has closed a second round of funding — taking $12 million from lead investor Octopus Ventures, along with participation from U.S.-based Existing investors in the April 2020-founded business also joined in the latest round of financing.
MedRhythms, a Portland, Maine-based digitaltherapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content